WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

WestGene-ESMO2024

More Like This

PR Newswire associated0

WestGene to Advance Clinical Trials Following Dual IND Approvals for World's First EB Virus-Related mRNA Therapeutic Cancer Vaccine

PR Newswire associated0

WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval

PR Newswire associated0

WestGene leads the way in mRNA innovation at the 4th mRNA Therapeutics Summit

PR Newswire associated0

WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit

PR Newswire associated0

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Business Wire logo

BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024

Bugworks Research Inc. to Present Poster at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2023, in Geneva, Switzerland

Business Wire logo

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023